[Attendance List, World Health Organization Meeting on Scientific and Public Health Rationale for HIV Vaccine Efficacy Trials (1994: Geneva, Switzerland)]

Dr E. Ga, Co t national de Laut contre le SIDA, B.P. 2113. Abidjan 04, C6te
COted'IvoiBe
Fax: [phone] Tel: [phone]
Dr A. Has, [Head, Department of Microbiology, University of Minsota, Box 196
UMHC, 420 Delaware St S, Minneapols, MN 55455-0312, USA
Fax: 612 626 b623 Tel [phone]
Dr I Jaffe, Director, Division of HIV-AIDS, Center for Infectious Disass CDC.
Atlanta, GA 30333, USA
Fax: [phone] Tel: [phone]~
Dr M. J,o. Division of AIDS, IAID, NL, 6003 FEActve Boevard Be
MD 2089Z USA
Fax: [phone] Tel: 301496 o45
Dr N, Director AIDS Spo Organisa Box 10443, Kaipala, Uganda
Fax: [phone] Te: 256 41 231138
Dr L. Ki National Institute of Public He Box 2784,11593 Stockhohm,
Sweden
Fax:[phone] TeL [phone]
r J.-. Levy, ecor, Agence Natio nae Se Recherche surle SIDA 66 bis avenueJeanMoulin, 750l Paris, Fance
Fa: 33 1 45 41 14 37 Tel: [phone]
Dr M. M5bdde. Mulago aHospital. Kampala, Uganda
Fa: 256 41 532282 Tel [phone]
Dr J. MIcNe& Chief, IV- IVa cine Prvention, Walter Reed Abmy Istitute, 13 Taft
Court, Rockvi, Msrssyad 205% USA
Fax: [phone] Tel [phone]
Dr J. M, The Aar Diamond AIDS Reseah Centr, 455 First Avenue, New Yor,
NY 10016, US4
Fax: [phone]:26 Tel: [phone]
Dr TL. Gei Ma MGuedI Rdmoige, DST/AIDS, Miisteio da Saude, Sobreloja,
Brasilia, Brazil
Fax: [phone] Te 55 61 225 7559
Dr EA RosLaniAbbin, Fransestsat 69 6524 HW Nijmegn, The NIaeterlan
Fax: [phone] Tel: [phone]
Dr A. S it, Chief, Vac Reseah &c Development, NIAID, N% 6003 Executive
Boulvar1I, Bj~esda, MD 20892. USA
Fax: [phone] TBl: 301 496 8200

OO/COOi 3hA3JN39 OHM 98L0T6L9TVOO~ CVCTCT 6 0i7 /8T